ESTEVE OPENS NEW CORPORATE HEADQUARTERS
As announced in September 2017, ESTEVE has moved the 400+ people who so far worked at company sites scattered across Barcelona to the new corporate headquarters located at the Zona Franca.
ESTEVE occupies 10 of the 13 stories of the Esteve Tower, a building that is part of the new business area of Barcelona where Iberdrola Inmobiliaria promotes 4 buildings: Torre Auditori, Torre Esteve, Torre Ponent, and Torre Llevant.
This move fulfills the long-sought-after goal of centralizing all work centers in a single site. One of the requirements for this move was selling the historic corporate headquarters at the quarter of Guinardó (Barcelona), a transaction that was finally part of the same global agreement reached with Iberdrola.
Team concentration at a single work center will help accelerate digitization, promote more aligned, collaborative, cross-cutting work, and encourage innovation.
The new building provides a structure that combines bright and open spaces with excellent finishing details. In addition, the Esteve Tower has a Class A Energy Performance Certificate and a "Very good" BREEAM rating, and stands out for its functionality, sustainability and energy savings, thus making this office complex a unique and sustainable business center in Barcelona.
New Sustainability Report
ESTEVE has just published its Sustainability Report with 2017 activity data in the economic, social and environmental fields, a document endorsed by the Global Report Initiative (GRI), entity an independent international that leads and fosters the development by companies of transparent and verifiable information.
THE PROGRAM ’PLAN PROFARMA’ HAS ONCE AGAIN QUALIFIED ESTEVE’S R&D&I AS ’’EXCELLENT’’
Once again, ESTEVE's research activity has received the qualification ''Excellent'' in the Program 'Plan Profarma' (Program for Fostering Scientific Research, Technological Development and Innovation ...read more
PENSA PHARMA HAS BEEN AWARDED A PRIZE FOR ITS BEST DEVELOPMENT AND COMMERCIALIZATION OF GENERIC MEDICINES
Pensa Pharma (PENSA), a company of the ESTEVE Group specialized in generic medicines, has been awarded a prize at the II edition of La Razón Comunidad Valenciana Awards. Specifically, PENSA has receiv...read more
ESTEVE APPOINTS THOMAS B. RIISAGER AS CHIEF CORPORATE STRATEGY & BUSINESS DEVELOPMENT OFFICER
ESTEVE has announced today the appointment of Thomas B Riisager as Chief Corporate Strategy & Business Development Officer, to be heading Corporate Strategy & Business Development for the pharmaceutic...read more